22.10.2019 01:46:42

Drug firms avert landmark opioid trial as talks on $48 billion settlement set to resume

Four large drug companies could resume talks on Tuesday to try to reach a $48 billion (£37.01 billion) settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal trial over their role in the U.S. opioid epidemic.
Weiter zum vollständigen Artikel bei "Reuters"

Eintrag hinzufügen

Handelsstreit sorgt für Auf und Ab | BX Swiss TV

Finanzen.net News

pagehit
FinanzenNet.Finando.Web.Core.Areas.Article.ViewModels.News.DetailsViewModel FinanzenNet.Finando.Web.Core.Extensions.VueComponent ;